Establishing assay cutoffs for HLA antibody screening of apheresis donors

Transfusion

Volumn 51, Issue 10, 2011, Pages 2092-2101

  Carrick, Danielle M ^a,b,c,d,e,f   Norris, Philip J ^a,b,c,d,e,f   Endres, Robert O ^a,b,c,d,e,f   Pandey, Suchitra ^a,b,c,d,e,f   Kleinman, Steven H ^a,b,c,d,e,f   Wright, David ^a,b,c,d,e,f   Sun, Yu ^a,b,c,d,e,f   Busch, Michael P ^a,b,c,d,e,f  

^a WESTAT   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CREATIVE TESTING SOLUTIONS   (United States)

^e Blood Centers of the Pacific   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADULT; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY TITER; ANTIGEN SPECIFICITY; APHERESIS; ARTICLE; BLOOD DONOR; FEMALE; HLA MATCHING; HUMAN; IMMUNOASSAY; MALE; MEDICAL HISTORY; PREGNANCY; PROBABILITY; RECIPIENT; SEROLOGY;

ACUTE LUNG INJURY; ADULT; BLOOD COMPONENT REMOVAL; BLOOD DONORS; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES; SEROLOGIC TESTS;

EID: 80054749098     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03048.x     Document Type: Article

References (19)

1. FDA US Food and Drug Administration, US Department of Health and Human Services. Fatalities reported to FDA following blood collection and transfusion: annual summary for Fiscal Year 2009. 2009.
2. Strong DM, Lipton KS,. AABB Association Bulletin. #06-07. 2006.
3. Popovsky MA, Moore SB,. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-7. (Pubitemid 16174471)
4. Middelburg RA, van Stein D, Briet E, van der Bom JG,. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008; 48: 2167-76.
5. Bux J, Sachs UJ,. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136: 788-99. (Pubitemid 46348408)
6. Nordhagen R, Conradi M, Dromtorp SM,. Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox Sang 1986; 51: 102-7. (Pubitemid 16046148)
7. Popovsky MA, Moore SB,. Autologous transfusion in Jehovah's witnesses. Transfusion 1985; 25: 444.
8. Silliman CC, Ambruso DR, Boshkov LK,. Transfusion-related acute lung injury. Blood 2005; 105: 2266-73. (Pubitemid 40387018)
9. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB,. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-35.
10. Endres RO, Kleinman SH, Carrick DM, Steele WR, Wright DJ, Norris PJ, Triulzi D, Kakaiya R, Busch MP,. Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion 2010; 50: 1749-60.
11. Kakaiya RM, Triulzi DJ, Wright DJ, Steele WR, Kleinman SH, Busch MP, Norris PJ, Hillyer CD, Gottschall JL, Rios JA, Carey P, Glynn SA,; National Heart, Lung, and Blood Institute (NHLBI) Retrovirus Epidemiology Donor Study-II. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010; 50: 1328-34.
12. Carrick DM, Johnson B, Kleinman SH, Vorhaben R, Change S, Lee JH, Pandey S, Roback J, Sun Y, Busch MP, Norris PJ,; for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Agreement amongst HLA antibody detection assays is higher in ever pregnant donors and improved using a consensus cutoff. Transfusion 2011; 51: 1105-16.
13. Kleinman S, Grossman B, Kopko P,. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States. Transfusion 2010; 50: 1312-21.
14. Mizutani K, Terasaki P, Hamdani E, Esquenazi V, Rosen A, Miller J, Ozawa M,. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 2007; 7: 1027-31. (Pubitemid 46481199)
15. Rios JA, Schlumpf KS, Kakaiya R, Triulzi D, Hillyer CD, Kleinman S, Busch MP, Gottschall JL, Carey P, Nemo G,. Blood donations from previously transfused or pregnant donors: a multi-center study to determine the frequency of allo-exposure. Transfusion 2010; doi: 10.1111/j.1537-2995.2010.02991.x.
16. Hashimoto S, Nakajima F, Kamada H, Kawamura K, Satake M, Tadokoro K, Okazaki H,. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury. Transfusion 2010; 50: 2582-91.
17. Triulzi DJ,. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009; 108: 770-6.
18. Andreu G, Vasse J, Herve F, Tardivel R, Semana G,. [Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients]. Transfus Clin Biol 2007; 14: 100-6. (Pubitemid 46874230)
19. Norris PJ, Lee JH, Carrick DM, Gottschall JL, Lebedeva M, de Castro BR, Kleinman SH, Busch MP,. Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma. Transfusion 2009; 49: 243-51.